Navigation Links
Aging to Be Reversed through Revolutionary New Category of Diagnostics
Date:9/23/2013

SANTA BARBARA, Calif., Sept. 23, 2013 /PRNewswire-iReach/ -- Active Life Scientific, Inc., develops a technology that enables the reversal and prevention of tissue degeneration, such as ailments experienced by the aging population. Active Life proudly announces the release of a white paper introducing their technological vision, coined Quantified Touch.

For ages, doctors have used their hands to touch patients in order to study and subjectively diagnose an array of diseases that can alter the physical properties of tissue.  The 'touch assay,' scientifically known as the physical and material properties of tissues, was enabled by world-renowned Dr. Paul Hansma's most recent invention, Reference Point Indentation.  The innovative concept is enabling previously impossible scientific discoveries and entirely new therapeutic approaches to precisely and objectively treat tissue degeneration.

Prolonged life expectancy is a great feat, however it does not translate to an increased quality of life. "Quantified Touch technologies are enabling a better understanding of the materials that determine our quality of life, facilitating an improved quality of life," stated Davis Brimer, Active Life's Co-founder and Chief Executive Officer, "this is directly in line with Active Life's vision."

The technical white paper provides detail into this new category of diagnostic assays that Active Life and its leading customers and collaborators are introducing around the globe; partnerships include some of the world's top pharmaceutical companies and renowned researchers. 

"Quantified Touch: A New Sense for Research and Diagnostics" is available to download here: http://www.activelifescientific.com/downloads/QuantifiedTouch.pdf

About Active Life
Active Life Scientific, Inc. is a Santa Barbara, CA based company that envisions a world where people live an excellent quality of life throughout their entire lifespan. The company provides cost-effective research and diagnostic instruments for translational testing of tissue health. Active Life enables the discovery, development, and medical practice of new treatments for preventing and reversing tissue degeneration. The Company's products are based on world renowned inventor Dr. Paul Hansma's latest breakthrough, Reference Point Indentation. For additional information, please contact Corporate Communications or visit www.activelifescientific.com.

Media Contact: Jennifer Rios, Active Life Scientific, Inc., +1 (805) 770-2600 x102, jen@activelifescientific.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Active Life Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sam Solakyan Successfully Expands Vital Imaging Across California
2. MR Solutions to Launch Two World Firsts in Pre Clinical Scanning at the World Molecular Imaging Conference in Savannah This Week - a Combined 3T, Cryogen Free MRI/PET and a 3T MRI/SPECT
3. Technology Innovation Provides Catalyst for Scientific Breakthroughs in Precision Medicine at World Molecular Imaging Congress
4. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging - Focus on Contract Packaging
5. Frost & Sullivan: Shortcomings in Medical Imaging Workflow Severely Impact Radiologists Productivity
6. Diagnostic Imaging Releases Recommendations For Greater Reading Room Comfort
7. Heart Imaging Technologies Announces the Release of its Web-Based Cardiac Echo Reporting Module
8. MPI Research Breaks Ground On New World-Class Imaging Center
9. Innophos To Present At 2013 KeyBanc Capital Markets Basic Materials & Packaging Conference
10. Global 3D Medical Imaging Industry
11. Heart Imaging Technologies Wins $2.5M NIH Grant for Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016 The U.S. ... for Jardiance (empagliflozin) to reduce the risk of cardiovascular ... and cardiovascular disease. "Cardiovascular disease is ... 2 diabetes mellitus," said Jean-Marc Guettier , M.D., ... Products in FDA,s Center for Drug Evaluation and Research. ...
(Date:12/2/2016)... December 2, 2016 Persistence Market ... market in its upcoming report titled, "Global Market Study on Cardiac ... CAGR of -1.4% between 2016 and 2024". The global cardiac ... 2015 and this is likely to decline to US$ ... global cardiac pacemaker market is anticipated to exhibit a ...
(Date:12/2/2016)... 2016 According to the latest market ... on Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product ... 2016 and 2024 " the global automated endoscope reprocessors market was valued at ... at a CAGR of 7.2% during an eight-year forecast period ... by 2024. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... ... California, will be included in the 2016 “Guide to America’s Top Plastic Surgeons” ... on the amalgamation of their education, experience, and professional associations. , One ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic ... a Heart at their tradeshow booth # 941 for the American Association of ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... journeys, announced today that it has raised $6.0 million in an initial round ... Clarify Health’s conviction that patients and their caregivers can receive far better care ...
(Date:11/30/2016)... ... November 30, 2016 , ... The ... been designated as a Cigna Infertility Center of Excellence. The Cigna Center of ... , “It’s an honor to be designated a Cigna Infertility Center of Excellence," ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... health treatment has announced the opening of a new residential mental health treatment ... with mental health issues such as severe anxiety, depression, bi-polar disorder, and other ...
Breaking Medicine News(10 mins):